Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,615
Closed -$71.7K 996
2023
Q1
$71.7K Sell
9,615
-294
-3% -$2.94K ﹤0.01% 1008
2022
Q4
$123K Buy
9,909
+1,945
+24% +$34.1K ﹤0.01% 1013
2022
Q3
$164K Sell
7,964
-693
-8% -$19.3K ﹤0.01% 1015
2022
Q2
$240K Sell
8,657
-3,655
-30% -$125K ﹤0.01% 959
2022
Q1
$538K Sell
12,312
-1,545
-11% -$67.2K 0.01% 422
2021
Q4
$765K Sell
13,857
-818
-6% -$50.5K 0.01% 403
2021
Q3
$907K Sell
14,675
-993
-6% -$65.4K 0.01% 401
2021
Q2
$1.33M Buy
15,668
+1,873
+14% +$171K 0.01% 372
2021
Q1
$1.09M Buy
13,795
+13
+0.1% +$844 0.01% 388
2020
Q4
$802K Buy
+13,782
New +$649K 0.01% 413
2016
Q2
Sell
-3,740
Closed -$140K 609
2016
Q1
$140K Sell
3,740
-177
-5% -$6.67K ﹤0.01% 614
2015
Q4
$279K Sell
3,917
-737
-16% -$50K ﹤0.01% 655
2015
Q3
$2.87K Buy
4,654
+1,779
+62% +$220K ﹤0.01% 655
2015
Q2
$387K Buy
+2,875
New +$276K ﹤0.01% 634

Other funds holding AFMD

ALPS Advisors's AFMD Position: Q2 2023 in Review

ALPS Advisors sold out of Affimed (AFMD) in Q2 2023, closing a stake of 9,615 shares — an estimated $71.7K sold.

ALPS Advisors first reported a position in AFMD in Q2 2015 and held it in 14 quarters. The position peaked at $1.33M in Q2 2021. 80 funds tracked by Wall St. Rank hold AFMD as of Q2 2023.

  • ALPS Advisors reported no remaining Affimed position as of Q2 2023 after selling out during the quarter.
  • ALPS Advisors sold 9,615 Affimed shares in Q2 2023, an estimated $71.7K.
  • ALPS Advisors first reported a position in Affimed in Q2 2015 and held it in 14 quarters.
  • ALPS Advisors's Affimed position peaked at $1.33M in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Affimed as of Q2 2023.

Based on ALPS Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.